UPDATE : Friday, July 19, 2019
상단여백
Samsung BioLogics’ fate remains uncertain amid litigating ups and downs by Lee Han-soo 2019-07-19 18:16
EU starts evaluating Samsung Bioepis’ sales application for Avastin biosimilar by Lee Han-soo 2019-07-19 17:01
Vaccines foreigners should get before visiting Korea for vacation by Lee Han-soo 2019-07-19 14:53
Celltrion targets Chinese biosimilar market through joint venture by Lee Han-soo 2019-07-19 14:53
Migrant worker group lashes mandatory health insurance subscription for foreigners by Lee Han-soo 2019-07-18 17:46
라인
‘Insurance benefits needed for Ibrance-fulvestrant combo treatment’ by Kim Yun-mi 2019-07-18 17:04
Bridge Biotherapeutics licenses out IPF treatment candidate to Boehringer by Lee Han-soo 2019-07-18 15:58
GC Labcell releases pre-clinical trial results for NK cell treatment by Lee Han-soo 2019-07-18 14:22
Sanofi vaccinates Gwangju FINA Championships staffs against hepatitis A by Lee Han-soo 2019-07-18 10:49
CrystalGenomics’ US partner starts injecting leukemia treatment candidate by Lee Han-soo 2019-07-17 17:45
라인
‘RIGHT Fund aims to use Korean innovation for global health equity’ by Lee Han-soo 2019-07-17 17:41
RIGHT Fund reveals 1st investment into public health projects in developing countries by Lee Han-soo 2019-07-17 14:03
'Biktarvy -- a pill a day to treat HIV' by Lee Han-soo 2019-07-17 10:09
Foreign doctors receive endoscopic ultrasonography training at AMC by Lee Han-soo 2019-07-16 14:29
JW wins EU patent for world's 1st early-stage pancreatic cancer detection by Lee Han-soo 2019-07-16 14:29
라인
Canon Medical Systems launch world's 1st CT deep-learning reconstruction software by Lee Han-soo 2019-07-16 11:37
Ono Pharma Korea names new CEO by Lee Han-soo 2019-07-16 11:24
Celltrion starts P1 trial of Xolair biosimilar by Lee Han-soo 2019-07-15 17:45
Daewoong, Medytox differ in interpreting US trade agency’s order by Lee Han-soo 2019-07-15 17:44
Self-claimed Korea Otsuka employee causes stir on far-right website by Lee Han-soo 2019-07-15 15:57
여백
여백
여백
Back to Top